The submission deadline has passed. The page is kept for reference. View active tenders →
Tender Details
Description / Scope of Work
The Pakistan Kidney and Liver Institute & Research Center (PKLI & RC) Lahore invites sealed competitive bids for the procurement of Iohexol-350 100ML Solution and Gadobutrol 1.0 Millimole/Milliliter 15 Milliliter Injection. This is a medical supplies procurement for diagnostic imaging agents essential for kidney and liver imaging procedures at the institute located in Lahore, Punjab. The tender reference is PRO-127-26, and bidding documents are available from the institute's procurement office. The exact quantities and estimated value are detailed in the bid data sheet and technical specifications sections of the bidding documents.
Eligible bidders must be registered pharmaceutical distributors or manufacturers authorized to supply these diagnostic contrast media in Pakistan. Bidders are required to submit documents establishing their eligibility, qualification, and the conformity of goods to specifications. A bid security deposit is mandated as per the tender terms, and all submissions must comply with DRAP Act 2012 and The Drug Act 1976 regulations. Technical specifications and detailed eligibility criteria are provided in the bidding documents.
Bidders must obtain complete bidding documents from PKLI & RC Lahore at 1 PKLI Avenue Opposite DHA Phase-6 Lahore, or contact the procurement department at Phone No: 042-111 117 554, Ext.3728. Sealed bids must be submitted by the deadline specified in the tender notice. Bids will be opened on the scheduled date in the presence of bidders or their representatives. All enquiries and clarifications should be directed to the procuring agency before the bid submission deadline.
For Bidders: Our Analysis PAKISTANTENDER INSIGHT
Independent analysis by PakistanTender — not part of the official notice. Always confirm details against the original tender document.
PKLI & RC seeks two diagnostic contrast agents (Iohexol-350 and Gadobutrol) for imaging procedures—likely recurring consumables given their clinical use in nephrology/hepatology.
Scale appears medium-to-large institutional demand. Notable: DRAP Act 2012 compliance mandatory; bidders need pharma distribution/manufacturing authorization. Exact quantities withheld until document acquisition, suggesting competitive sensitivity. Standard 10-month closure allows document preparation but indicates deliberate procurement planning.
Who can bid: Bidders must be registered pharmaceutical distributors or manufacturers with DRAP authorization to supply diagnostic contrast media in Pakistan. DRAP Act 2012 and Drug Act 1976 compliance required. Likely require NTN, PEC (if applicable), and DRAP licensing documentation. Typically, bidders must demonstrate import/distribution credentials and product registration certificates.